Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura
โ Scribed by F. Ferrara; C. Copia; M. Annunziata; A. Spasiano; C. Di Grazia; S. Palmieri; L. Prossomariti; G. Mele
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 65 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Plasma exchange (PE) is considered first-line treatment for thrombotic thrombocytopenic purpura (TTP) to the point that many clinicians regard it as definitive therapy. Studies have reported response rates to PE ranging from 39% to 78%. In our experience, a minority of patients have been cured solel
## Abstract Plasma exchange is the standard treatment for thrombotic thrombocytopenic purpura (TTP). For patients refractory to plasma exchange, treatment options are limited and often unsuccessful. The platelet thrombi that form in acquired TTP are believed to result from the presence of procoagul